Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-03-07

Clinical Trial Update: Fluor Varnish With Silver Nanoparticles for Dental Remineralization in Patients With Trisomy 21 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Fluor Varnish With Silver Nanoparticles for dental remineralization in individuals with Down syndrome (Trisomy 21).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluor Varnish With Silver Nanoparticles (fluor varnish with silver nanoparticles)

Snippet

Sponsor: Universidad Autonoma de San Luis Potosí | Conditions: Down Syndrome | Phase 2 | Status: UNKNOWN